drugset / Trial / NCT06697522
Study of Atropine Sulfate Eye Drops(0.01%) in Treating Near-work-induced Transient Myopia in Children
Phase 3
Completed
148 enrolled
Ocumension Therapeutics (Suzhou) Co., Ltd
Beijing Children's Hospital · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is a randomized, double-blind, placebo-controlled, parallel-group study to evaluate the safety and efficacy of atropine sulfate eye drops (0.01%) in treating transient myopia induced by near work tasks (NITM) in pediatric subjects.
Timeline
- Start
- 2023-06-25
- Primary completion
- 2023-10-06
- Completion
- 2024-03-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atropine | Other / unclassified | 0.01 % | Other |